| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/09/2010 | US7659115 Nucleic acid encoding human transductin-1 polypeptide |
| 02/09/2010 | US7659114 Recombinant feline herpesvirus type 1 and polyvalent vaccine using the same |
| 02/09/2010 | US7659112 Using transgenic worms as bioreactors for propagation of cytokine proteins |
| 02/09/2010 | US7659094 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/09/2010 | US7659093 DAP12 nucleic acids |
| 02/09/2010 | US7659092 Comprising a non-cytotoxic protease capable of cleaving a protein of the exocytic fusion apparatus of a nociceptive sensory afferent |
| 02/09/2010 | US7659076 Binding of pathological forms of prion proteins |
| 02/09/2010 | US7659071 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN) |
| 02/09/2010 | US7659065 Transgenic fungi expressing Bcl-2 and methods of using Bcl-2 or portions thereof for improving biomass production, survival, longevity and stress resistance of fungi |
| 02/09/2010 | US7659058 Vectors containing promoters; contacting with lymphocytes; inducting antigen presenting cells transduced with vector; encoding marking gene; gene transfer vectors |
| 02/09/2010 | US7659055 Fragments of nucleic acids specific to mycobacteria which are members of the M. tuberculosis complex and their applications for the detection and the differential diagnosis of members of the M. tuberculosis complex |
| 02/09/2010 | US7658935 Methods and compositions for stimulating the immune system |
| 02/09/2010 | US7658934 Chlamydia antigens and protein vaccine |
| 02/09/2010 | US7658933 Non-cytotoxic protein conjugates |
| 02/09/2010 | US7658932 removal of structural features of HIV that interfere with immune response. In particular, sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding, CD55 and CD59 removal prevent the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 02/09/2010 | US7658931 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 02/09/2010 | US7658929 Derived from pathogenic microorganisms, useful for vaccination and diagnosis; tuberculosis; detection of CD4+ T lymphocytes recognizing at least one glycopeptide obtained from pathogenic microorganism |
| 02/09/2010 | US7658927 Materials and methods for immunizing against FIV infection |
| 02/09/2010 | US7658920 Method of inhibiting the activity of growth factor homolog ZVEGF3 |
| 02/09/2010 | US7658917 A beta aggregation core domain and a modifying group coupled thereto such that the compound alters the aggregation or inhibits the neurotoxicity of natural beta amyloid peptides when contacted with the peptides. |
| 02/09/2010 | CA2592180C Nanographite structure/metal nanoparticle composite |
| 02/09/2010 | CA2466372C Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 02/09/2010 | CA2404945C Taci as an anti-tumor agent |
| 02/09/2010 | CA2392033C Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 02/09/2010 | CA2378431C Peptides that lower blood glucose levels |
| 02/09/2010 | CA2372666C Methods for predicting pregnancy outcome in a subject by hcg assay |
| 02/09/2010 | CA2370694C Extraction of integral membrane proteins |
| 02/09/2010 | CA2363934C Oligomers substituted by phosphite ester, phosphonic acid,or carbaborane functions and the corresponding pna monomers |
| 02/09/2010 | CA2350417C Dna-protein fusions and uses thereof |
| 02/09/2010 | CA2349875C Dna encoding a growth factor specific for epithelial cells |
| 02/09/2010 | CA2295878C Increasing production of proteins in gram-positive microorganisms |
| 02/09/2010 | CA2293806C Alpha 1-antitrypsin preparation as well as a method for producing the same |
| 02/09/2010 | CA2256532C Immunodominant 120 kda surface-exposed adhesion protein genes of ehrlichia chaffeensis |
| 02/09/2010 | CA2235810C Senescent cell-derived inhibitors of dna synthesis |
| 02/09/2010 | CA2205910C Plasmids suitable for il-2 expression |
| 02/09/2010 | CA2195799C Bacterial production of hydrophobic polypeptides |
| 02/04/2010 | WO2010014946A2 Halogen-stabilized insulin |
| 02/04/2010 | WO2010014922A2 Protein purification tags and uses thereof |
| 02/04/2010 | WO2010014746A1 Materials and methods for treatment of spinal muscular atrophy and taxane-induced peripheral neuropathy (tipn) |
| 02/04/2010 | WO2010014629A1 Multi-specific binding proteins targeting b cell disorders |
| 02/04/2010 | WO2010014608A1 Methods and compositions for inhibition of neutrophil exocytosis |
| 02/04/2010 | WO2010014304A1 Compositions and methods related to staphylococcal bacterium proteins |
| 02/04/2010 | WO2010013836A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
| 02/04/2010 | WO2010013830A1 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same |
| 02/04/2010 | WO2010013762A1 Metastin derivative and use thereof |
| 02/04/2010 | WO2010013012A2 Novel polypeptides and uses thereof |
| 02/04/2010 | WO2010012972A2 Novel bacterial cells and uses thereof |
| 02/04/2010 | WO2010012948A2 Combination of two genetic elements for controlling the floral development of a dicotyledonous plant, and use in detection and selection methods |
| 02/04/2010 | WO2010012834A1 Method for the in vitro diagnosis of stroke |
| 02/04/2010 | WO2010012829A1 Her2/neu specific t cell receptors |
| 02/04/2010 | WO2010012509A1 Method for the in vitro diagnosis of stroke |
| 02/04/2010 | WO2010012452A1 Bag-1 peptide that inhibits prostate cancer |
| 02/04/2010 | WO2009139887A3 Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue |
| 02/04/2010 | WO2009090227A3 PEPTIDES HAVING BINDING AFFINITY TO AN ANTIBODY WHICH RECOGNIZES AN EPITOPE ON AN α1 LOOP 2 OR β2 LOOP 1 OF AN ADRENORECEPTOR |
| 02/04/2010 | WO2004099365A9 Transcription factor gene induced by water deficit conditions and abscisic acid from helianthus annuus, promoter and transgenic plants |
| 02/04/2010 | WO2003076575A9 The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| 02/04/2010 | WO2003072064A9 Methods and compositions for regulating adipogenesis |
| 02/04/2010 | WO2003063798A9 Compositions and methods for treatment of infectious and inflammatory diseases |
| 02/04/2010 | US20100031401 Precise breeding |
| 02/04/2010 | US20100031398 Genes encoding chavicol/eugenol synthase from the creosote bush larrea tridentata |
| 02/04/2010 | US20100031397 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 02/04/2010 | US20100031396 and processing of transgenic sugarcane using a nucleic acid encoding the promoter of a Sugarcane Elongation Factor (SEF) |
| 02/04/2010 | US20100031395 Photosyntheticorganisms and compositions and methods of generating same |
| 02/04/2010 | US20100031394 Human Blood Proteins Expressed in Monocot Seeds |
| 02/04/2010 | US20100031393 Novel protein having acyltransferase activity and gene encoding the same |
| 02/04/2010 | US20100030543 Products and processes for modulating peptide-peptide binding domain interactions |
| 02/04/2010 | US20100029922 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 02/04/2010 | US20100029920 Method for assessing the effect of a drug on long term memory formation |
| 02/04/2010 | US20100029913 Biocompatible phase invertible proteinaceous compositions and methods for making and using the same |
| 02/04/2010 | US20100029912 Fusion Protein |
| 02/04/2010 | US20100029911 Method For Solid-Phase Peptide Synthesis And Purification |
| 02/04/2010 | US20100029910 Nanographite structure/metal nanoparticle composite |
| 02/04/2010 | US20100029909 Compositions and methods comprising magnetic resonance contrast agents |
| 02/04/2010 | US20100029908 Absorbable sponge with contrasting agent |
| 02/04/2010 | US20100029907 Peptide-polymer conjugates |
| 02/04/2010 | US20100029906 Synthetic mimics of mammalian cell surface receptors: method and compositions |
| 02/04/2010 | US20100029903 Polypeptide Protracting Tags |
| 02/04/2010 | US20100029751 Compositions comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis |
| 02/04/2010 | US20100029573 Tumor-associated peptides that bind to mhc-molecules |
| 02/04/2010 | US20100029570 Peptide and treatment for hiv-1 infection |
| 02/04/2010 | US20100029565 RECOMBINANT B. pseudomallei ADHESIN PROTEIN AND METHODS AND USES THEREOF |
| 02/04/2010 | US20100029563 administering a composition comprising a GM-CSF cysteine mutein of SEQ ID NO:8, wherein a cysteine residue is substituted for an amino acid selected from the group consisting of A1, A3, S5, S7, N27, T32, A33, E51, R67, S69, E93, T94, T98, Q99, T102, E123, V125, Q126, and E127 |
| 02/04/2010 | US20100029555 G-csf site-specific mono-conjugates |
| 02/04/2010 | US20100029554 Composition and Methods for Treatment of Congestive Heart Failure |
| 02/04/2010 | US20100029553 Microfluidic Device for Controlled Aggregation of Spider Silk |
| 02/04/2010 | US20100029552 Peptide inhibitors of c-jun dimerization and uses thereof |
| 02/04/2010 | US20100029548 Glycoproteins produced in plants and methods of their use |
| 02/04/2010 | US20100029547 Mvl, an antiviral protein from a cyanobacterium |
| 02/04/2010 | US20100029499 Artificial Protein Scaffolds |
| 02/04/2010 | US20100029494 Macromolecular Nucleotide Compounds And Methods For Using The Same |
| 02/04/2010 | US20100029489 Sucrose transport proteins |
| 02/04/2010 | US20100029007 Biomarker in Inflammatory Diseases |
| 02/04/2010 | US20100028995 Tetranectin Trimerizing Polypeptides |
| 02/04/2010 | US20100028993 Methods of producing peptides in plants and peptides produced thereby |
| 02/04/2010 | US20100028947 Use of human cells of myeloid leukaemia origin for expression of antibodies |
| 02/04/2010 | US20100028945 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor |
| 02/04/2010 | US20100028942 Methods for Improving Viability and Productivity in Cell Culture |
| 02/04/2010 | US20100028939 Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic Interest |
| 02/04/2010 | US20100028905 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 02/04/2010 | US20100028882 Methods for diagnosing osteoarthritis |